Showing all published months. Partner preview tables include up to 20 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 20 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Puerto Rico | $1.8B | 48.2% |
| France | $408.6M | 11.0% |
| Germany | $392.3M | 10.6% |
| United Kingdom | $186M | 5.0% |
| Ireland | $174.8M | 4.7% |
| United States | $173.2M | 4.7% |
| Italy | $145.9M | 3.9% |
| Slovenia | $112.7M | 3.0% |
| Spain | $112.1M | 3.0% |
| Belgium | $101.3M | 2.7% |
| Greece | $38.1M | 1.0% |
| Canada | $32M | 0.9% |
| Sweden | $21.4M | 0.6% |
| Türkiye | $18.4M | 0.5% |
| India | $630.8K | 0.0% |
| Vietnam | $315.5K | 0.0% |
| Japan | $73.4K | 0.0% |
| Australia | $4.5K | 0.0% |
| Taiwan | $3.5K | 0.0% |
| Hong Kong，China | $473 | 0.0% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| Puerto Rico | $27.7M | 32.4% |
| Ireland | $14.4M | 16.9% |
| Slovenia | $11.7M | 13.7% |
| Germany | $11.6M | 13.6% |
| France | $10.9M | 12.7% |
| United States | $4.4M | 5.2% |
| United Kingdom | $2.7M | 3.2% |
| Belgium | $1.2M | 1.4% |
| Greece | $569.4K | 0.7% |
| Canada | $168.1K | 0.2% |
| Italy | $7.8K | 0.0% |
| Spain | $6.7K | 0.0% |
| Australia | $294 | 0.0% |
| Year | Import value |
|---|---|
| 2021 | $485.6M |
| 2022 | $608.9M |
| 2023 | $776.2M |
| 2024 | $569.4M |
| 2025 | $694.3M |
| 2026 | $568.3M |
Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.
HS 30049010 is also written 3004.90.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Sulfonamide-based pharmaceutical preparations formulated into retail packages or measured doses for therapeutic or prophylactic application. The public page shows monthly import partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of sulfa drugs, in measured doses or in retail packings (HS 30049010) Import Data." https://chinadata.live/china-trade/hs8/30049010/
HS 30049010 is also written 3004.90.10. Values are in USD; the public series does not report tonnes or kg. Product scope: Sulfonamide-based pharmaceutical preparations formulated into retail packages or measured doses for therapeutic or prophylactic application. The public page shows monthly import partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of sulfa drugs, in measured doses or in retail packings (HS 30049010) Import Data." https://chinadata.live/china-trade/hs8/30049010/
China imported $856M of medicaments of sulfa drugs, in measured doses or in retail packings in the twelve months to July 2026, averaging $71.3M per month, based on official China customs statistics (HS 30049010).
Sulfonamide-based pharmaceutical preparations formulated into retail packages or measured doses for therapeutic or prophylactic application.
Puerto Rico, France and Germany together account for 70% of the published total, out of 16 trading partners on record.
Annual imports grew by 43% between 2021 and 2025, from $486M to $694M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.